Atlas Trials

Timolol Gel for Epistaxis in Hereditary Hemorrhagic Telangiectasia

Clinical trial NCT04139018 · COMPLETED

Trial details

NCT number
NCT04139018
Sponsor
Washington University School of Medicine
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Hereditary Hemorrhagic Telangiectasia
Start date
2019-10-20
Primary completion
2020-05-20
Enrollment
27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.